| For: | Low ES, Apostolov R, Wong D, Lin S, Kutaiba N, Grace JA, Sinclair M. Hepatocellular carcinoma surveillance and quantile regression for determinants of underutilisation in at-risk Australian patients. World J Gastrointest Oncol 2021; 13(12): 2149-2160 [PMID: 35070048 DOI: 10.4251/wjgo.v13.i12.2149] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v13/i12/2149.htm |
| Number | Citing Articles |
| 1 |
Leon A. Adams, Deborah de Guingand, Gary P. Jeffrey, Alexander J. Thompson, Simone I. Strasser, Darrell Crawford, Louisa Collins, Christopher Reid, Michael Wallace, Patty Chondros, Nicole Allard, Andrew Kirke, Claudia Rutherford, Charlotte Hespe, Riitta Partanen, Sophie Frear, Holly Napreet, Katerina Piakis, Cailin Maas, Olivia J. White, Adrian Laughlin, Tara Clinton-McHarg, Caitlin Clymer, Lucy Boyd, Jon Emery. The IC3 trial: protocol for a multicentre individually randomised controlled trial to compare a cirrhosis detection and hepatocellular carcinoma surveillance pathway vs usual care in Australian general practice for 45–75 years old with risk factors for chronic liver disease. Trials 2025; 26(1) doi: 10.1186/s13063-025-09037-9
|
| 2 |
Jonathan Abdelmalak, Simone I. Strasser, Natalie L. Ngu, Claude Dennis, Marie Sinclair, Avik Majumdar, Kate Collins, Katherine Bateman, Anouk Dev, Joshua H. Abasszade, Zina Valaydon, Daniel Saitta, Kathryn Gazelakis, Susan Byers, Jacinta Holmes, Alexander J. Thompson, Jessica Howell, Dhivya Pandiaraja, Steven Bollipo, Suresh Sharma, Merlyn Joseph, Rohit Sawhney, Amanda Nicoll, Nicholas Batt, Myo J. Tang, Stephen Riordan, Nicholas Hannah, James Haridy, Siddharth Sood, Eileen Lam, Elysia Greenhill, Daniel Clayton-Chubb, John Lubel, William Kemp, Ammar Majeed, John Zalcberg, Stuart K. Roberts. Early-Stage Australian HCC Patients Treated at Tertiary Centres Show Comparable Survival Across Metropolitan and Non-Metropolitan Residency. Livers 2026; 6(1): 2 doi: 10.3390/livers6010002
|
| 3 |
Samuel Hui, Andrew Nguyen, Suong Le, Anouk Dev, Sally Bell. Clinical outcomes of hepatocellular carcinoma surveillance in Melbourne, Australia. Internal Medicine Journal 2024; 54(8): 1360 doi: 10.1111/imj.16405
|
| 4 |
Samuel Hui, Sally Bell, Suong Le, Anouk Dev. Hepatocellular carcinoma surveillance in Australia: current and future perspectives. Medical Journal of Australia 2023; 219(9): 432 doi: 10.5694/mja2.52124
|
| 5 |
Chun-Wei Pan, Pojaskorn Danpanichkul, Ramsey Cheung, Paulo Pinheiro, Patricia D. Jones, Robert J. Wong. Trends in Urban-rural Disparities in Hepatocellular Carcinoma Mortality in the United States From 1999 to 2020. Journal of Clinical Gastroenterology 2025; doi: 10.1097/MCG.0000000000002162
|
| 6 |
Samuel Hui, Nikhita Sane, Andrew Wang, Leo Wan, Sally Bell, Suong Le, Anouk Dev. Hepatocellular carcinoma surveillance in the telehealth era: A single-centre review. Journal of Telemedicine and Telecare 2025; 31(1): 64 doi: 10.1177/1357633X231166032
|
| 7 |
Cameron Gofton, Anna Di Bartolomeo, Shalini Wijekulasuriya, Shenghan Cai, Rose Boutros, Fiona Stafford-Bell, Kim Caldwell, Geoffrey McCaughan, Amany Zekry, Simone I Strasser, Miriam Levy, Caitlin Sheehan, Stephen Goodall, Jan Maree Davis, Linda Sheahan, Ken Liu, Sally Greenaway, Scott Davison, Thang Du Huynh, Zujaj Quadri, Yvonne A Zurynski, Meera Agar, Jacob George. Palliative and supportive care in patients with hepatocellular carcinoma: a qualitative study on attitudes and perceptions of health professionals. Supportive Care in Cancer 2025; 33(5) doi: 10.1007/s00520-025-09403-y
|
| 8 |
Samuel Hui, Adam Irving, Suong Le, Anouk Dev, Sally Bell. Price threshold analysis of biomarker surveillance for hepatocellular carcinoma in Australia. Hepatoma Research 2025; doi: 10.20517/2394-5079.2025.25
|
